Philip E. Castle - Concepedia

Author

Philip E. Castle

Also Known As

Alan Waxman, Castle, Philip, Huchko, M.J., Maire Duggan, P E Castle, P. Castle, P. E Castle, P. E. CASTLE, P. E. Castle, P.E Castle

515

Publications

37.3K

Citations

H-Index

152

Concepts

All Affiliations

National Cancer Institute Albert Einstein College of Medicine National Institutes of Health Division of Cancer Epidemiology and Genetics Kaiser Permanente

About

Philip E. Castle is an author at National Cancer Institute specializing in medicine, cervical cancer, and human papillomavirus vaccines.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	42	83	10.9K
2	Public Health	38	73	8.8K
3	Engineering	3	3	230
4	Health Sciences	2	2	40
5	Management	1	1	37

Philip E. Castle

277

Publications

27.3K

Citations

H-Index

Page 1

	Year	Citations
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer Debbie Saslow, Diane Solomon, Herschel W. Lawson, CA A Cancer Journal for Clinicians GynecologyPathologyAmerican SocietyCytopathologyGynecology Oncology	2012	1.4K
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors Rebecca B. Perkins, Richard S. Guido, Philip E. Castle, Journal of Lower Genital Tract Disease	2020	1.2K
The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice Michelle J. Khan, Philip E. Castle, Attila T. Lörincz, JNCI Journal of the National Cancer Institute	2005	1K
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer Debbie Saslow, Diane Solomon, Herschel W. Lawson, American Journal of Clinical Pathology GynecologyPathologyAmerican SocietyCytopathologyGynecology Oncology	2012	785
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older Chris J.L.M. Meijer, Johannes Berkhof, Philip E. Castle, International Journal of Cancer Candidate HpvDiagnosisGynecologyPathologyCytopathology	2008	683
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice Hormuzd A. Katki, Walter Kinney, Barbara Fetterman, The Lancet Oncology Cervical CytologyPrecancerous LesionsGynecologyGynecology OncologyCancer-associated Virus	2011	563
The carcinogenicity of human papillomavirus types reflects viral evolution Mark Schiffman, Rolando Herrero, Rob DeSalle, Virology Viral EvolutionCervical CancerHuman Papillomavirus VaccinesPathogenesisPathology	2005	557
Rapid Clearance of Human Papillomavirus and Implications for Clinical Focus on Persistent Infections Ana Cecilia Rodríguez, Mark Schiffman, Rolando Herrero, JNCI Journal of the National Cancer Institute Clinical FocusViral DiagnosticsEpidemiology Of CancerPathologyGynecology	2008	536
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study Philip E. Castle, Mark H. Stoler, Thomas C. Wright, The Lancet Oncology Cervical Cancer ScreeningEpidemiologyCervical CancerCervical HealthHuman Papillomavirus Vaccines	2011	514
Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study Kate T. Simms, Julia Steinberg, Michael Caruana, The Lancet Oncology Epidemiology Of CancerModelling StudyVaccine HesitancyCervical Cancer PreventionPreventive Medicine	2019	473

Page 1